
Epizyme EPZM
Quarterly report 2022-Q2
added 08-09-2022
Epizyme Historical Prices 2011-2025 | EPZM
Annual Historical Prices Epizyme
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.23 | 10.9 | 20.9 | 10.2 | 16.1 | 10.5 | 9.09 | 19.1 | 30.4 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 30.4 | 1.23 | 14.3 |
Historical Prices of other stocks in the Biotechnology industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M | ||
|
Alpine Immune Sciences
ALPN
|
8.04 | - | - | $ 2.17 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
27 | $ 25.37 | -2.07 % | $ 1.23 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
2.68 | $ 4.75 | 1.61 % | $ 788 M | ||
|
Aclaris Therapeutics
ACRS
|
1.97 | $ 3.28 | -2.53 % | $ 254 M | ||
|
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | ||
|
Acasti Pharma
ACST
|
3.37 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
1.7 | - | -15.15 % | $ 60.3 M | ||
|
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | ||
|
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | ||
|
Ascendis Pharma A/S
ASND
|
153 | $ 210.49 | 0.16 % | $ 5 B | ||
|
Albireo Pharma
ALBO
|
28.5 | - | -0.23 % | $ 916 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.5 | - | - | $ 7.46 M | ||
|
Aptorum Group Limited
APM
|
0.75 | $ 1.31 | -1.88 % | $ 7.14 M | ||
|
Alterity Therapeutics Limited
ATHE
|
0.58 | $ 3.34 | -2.47 % | $ 8.04 B | ||
|
Anika Therapeutics
ANIK
|
25.4 | $ 9.56 | 0.75 % | $ 140 M | ||
|
Brickell Biotech
BBI
|
2.11 | - | -5.38 % | $ 6.06 M | ||
|
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
0.27 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
1.7 | - | -7.31 % | $ 87 M | ||
|
Aytu BioScience
AYTU
|
2.51 | $ 2.35 | 3.07 % | $ 14.8 M | ||
|
Arena Pharmaceuticals
ARNA
|
92.9 | - | -6.81 % | $ 3.04 B | ||
|
AstraZeneca PLC
AZN
|
74.2 | $ 89.88 | -0.46 % | $ 96.9 B | ||
|
Baudax Bio
BXRX
|
2.35 | - | 0.59 % | $ 63 K | ||
|
Avenue Therapeutics
ATXI
|
0.42 | - | -52.27 % | $ 4.45 M | ||
|
ChromaDex Corporation
CDXC
|
5.67 | - | -0.88 % | $ 598 M | ||
|
Axon Enterprise
AXON
|
526 | $ 568.3 | -2.19 % | $ 43 B | ||
|
Checkpoint Therapeutics
CKPT
|
4.04 | - | - | $ 169 M | ||
|
Caladrius Biosciences
CLBS
|
0.43 | - | -16.75 % | $ 25.8 M | ||
|
Clovis Oncology
CLVS
|
2.04 | - | -7.23 % | $ 13 M | ||
|
Biogen
BIIB
|
133 | $ 174.78 | 1.32 % | $ 25.4 B | ||
|
BioVie
BIVI
|
1.65 | $ 1.46 | -3.31 % | $ 2.16 M | ||
|
Cortexyme
CRTX
|
1.88 | - | -1.05 % | $ 67.1 M | ||
|
Benitec Biopharma
BNTC
|
13.5 | $ 12.34 | -4.78 % | $ 508 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
14.1 | - | - | $ 2.18 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
133 | $ 11.5 | 0.52 % | $ 744 M | ||
|
BioNTech SE
BNTX
|
95.4 | $ 94.85 | -1.2 % | $ 27.2 B | ||
|
Eloxx Pharmaceuticals
ELOX
|
2.84 | - | -5.68 % | $ 8.28 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
1.45 | $ 0.28 | -2.28 % | $ 609 M | ||
|
Catalyst Biosciences
CBIO
|
0.51 | $ 14.62 | -4.54 % | $ 962 M | ||
|
Acer Therapeutics
ACER
|
0.77 | - | 2.71 % | $ 14 M | ||
|
Cerus Corporation
CERS
|
1.63 | $ 2.17 | 0.7 % | $ 401 M | ||
|
Enochian Biosciences
ENOB
|
0.7 | - | - | $ 40.5 M | ||
|
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | ||
|
Applied Molecular Transport
AMTI
|
0.57 | - | - | $ 10.1 M | ||
|
Burford Capital Limited
BUR
|
10.6 | $ 9.15 | 0.16 % | $ 1.5 B |